Global investment firm KKR is in talks to acquire Leixir Dental Laboratory Group from Comvest Investment Partners at a valuation of $200-$250 million. Leixir, founded in 2013, offers various dental solutions and operates facilities in the US and India. Deloitte is advising on the sale process.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Aeon5HM
via IFTTT
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(206)
-
▼
March
(65)
- View: Will Trump's tariffs lift the veil on India'...
- Ankura Hospitals secures Rs 165 cr funding from ADB
- KKR in talks to acquire US dental labs chain Leixir
- From AI to Telemedicine: Digital skills every heal...
- Eli Lilly working on a heart drug that may benefit...
- 47 drugs found 'not of standard quality' in February
- Essential medicines will cost you a bit more from ...
- Kedaara, TA Associates vie for minority stake in S...
- Donor aid cuts may undo years of progress in comba...
- Delhi HC asks Natco Pharma to pause Risdiplam laun...
- Open to tie-ups in India for selling Mounjaro: Eli...
- Eli Lilly's goal is to reach everyone who needs ob...
- India develops its first indigenous MRI machine, t...
- Meghalaya’s Gnanamma Healthcare Centre transitions...
- Delhi HC rejects Roche's plea to block Natco Pharm...
- Heartening news: Device made in India to help tran...
- ₹14,000 per month weight-loss shot is here to cash...
- Bharat Biotech invests Rs 600 cr to expand into ce...
- Entero Healthcare launches HealthEdge programme fo...
- Eli Lilly launches weight-loss drug Mounjaro in In...
- India has a chance to lead in health space amid Gl...
- Impose safeguard duties on medical devices: AiMeD
- AI, teleconsultation, modern tech being used in tr...
- Health expenditure now at 1.84 pc of GDP, moving s...
- Zydus Lifesciences gets USFDA nod to produce prost...
- India weighs lower tariffs for US medical devices ...
- Gene therapy for blood cancer shows 73 per cent re...
- AIIMS critically short of staff amid land & budget...
- Sun Pharma, Zydus recall products in US: USFDA report
- Skin cream, nasal spray, and... blindness? AIIMS d...
- Struggling with dry eyes? Haldi's power-packed com...
- China’s biotech is redrawing the global pharma map...
- Parliamentary panel flags brain drain from health ...
- Parl panel on health: Cos scared to set up units d...
- Dr. Reddy’s recalls mislabelled Levetiracetam inje...
- Indian generic drugs linked to deaths in US? Trade...
- Global buyout funds line up for AGS Health
- New affordable diabetes drug Empagliflozin launche...
- Zydus eyes major stake in French medtech Amplitude...
- India, vaccine superpower; manufactures 60% of glo...
- Zydus Lifesciences to buy 86% stake in French medi...
- ET Q&A: All our products are legitimate, sold unde...
- India's Syngene International acquires first US bi...
- Zydus Lifesciences gets USFDA nod to market generi...
- Sun Pharmaceuticals to acquire Checkpoint Therapeu...
- Keep tobacco and alcohol ads and their proxies off...
- USFDA pulls up Granules India for lapses in mainta...
- Protecting your heart and managing diabetes: The p...
- Indian Pharmaceutical Alliance calls for zero impo...
- Registration for Ayushman Bharat to start after Ma...
- Apollo Health picks up controlling stake in Luckno...
- AstraZeneca gets nod to import, sell hyperkalaemia...
- Lasik surgery in 10 seconds? This AI-powered tech ...
- Clinical research entities asked to register by Ap...
- Aurobindo unit terminates pact with Singapore firm...
- India set to introduce list of OTC drugs this month
- Senores Pharma to acquire 14 ANDAs from Dr Reddy's...
- Zydus to develop combination vaccine for shigellos...
- Diabetes and obesity: The dangerous duo you need t...
- AstraZeneca Pharma India gets CDSCO approval to im...
- Sun Pharma aims to launch anti-obesity and type 2 ...
- Glenmark acquires Acetylcysteine injection, launch...
- Glenmark recalls 15 lakh bottles of ADHD medicatio...
- Reciprocal tariffs may make Indian generic drugs c...
- Our healthcare, education systems being plagued by...
-
▼
March
(65)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment